Acetarsol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB13268 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 48 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | leishmaniasis, diffuse cutaneous | KG + DL |
| 2 | mucocutaneous leishmaniasis | KG + DL |
| 3 | X-linked lymphoproliferative syndrome | KG + DL |
| 4 | type 2 diabetes nephropathy | KG + DL |
| 5 | streptococcal pneumonia | KG + DL |
| 6 | squamous cell lung carcinoma | KG + DL |
| 7 | Legionnaires’ disease | KG + DL |
| 8 | rete ovarii cystadenoma | KG + DL |
| 9 | ovarian benign neoplasm | KG + DL |
| 10 | ovarian papillary cystadenoma | KG + DL |
| 11 | ovarian surface papilloma | KG + DL |
| 12 | ovarian mucinous cystadenofibroma | KG + DL |
| 13 | mucinous ovarian cystadenoma | KG + DL |
| 14 | borderline ovarian serous tumor | KG + DL |
| 15 | Pontiac fever | KG + DL |
| 16 | malignant ovarian Brenner tumor | KG + DL |
| 17 | hemophagocytic syndrome associated with an infection | KG + DL |
| 18 | acquired hemophagocytic lymphohistiocytosis associated with malignant disease | KG + DL |
| 19 | serous neoplasm | KG + DL |
| 20 | aleukemic mast cell leukemia | KG + DL |
| 21 | pyelonephritis | KG + DL |
| 22 | mucinous ovarian cancer | KG + DL |
| 23 | mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies | KG + DL |
| 24 | ovarian clear cell cancer | KG + DL |
| 25 | schistosomiasis | KG + DL |
| 26 | disorder of tyrosine metabolism | KG + DL |
| 27 | idiopathic interstitial pneumonia | KG + DL |
| 28 | tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria | KG + DL |
| 29 | diabetic neuropathy | KG + DL |
| 30 | teratogenic Pierre Robin syndrome | KG + DL |
| 31 | influenza, severe, susceptibility to | KG + DL |
| 32 | uterine corpus myxoid leiomyosarcoma | KG + DL |
| 33 | diabetic polyneuropathy | KG + DL |
| 34 | uterine corpus epithelioid leiomyosarcoma | KG + DL |
| 35 | anus leiomyosarcoma | KG + DL |
| 36 | small intestinal sarcoma | KG + DL |
| 37 | retroperitoneal sarcoma | KG + DL |
| 38 | leiomyosarcoma | KG + DL |
| 39 | non-specific interstitial pneumonia | KG + DL |
| 40 | idiopathic pleuroparenchymal fibroelastosis | KG + DL |
| 41 | combined pulmonary fibrosis-emphysema syndrome | KG + DL |
| 42 | classic variant of chromophobe renal cell carcinoma | KG + DL |
| 43 | clear cell renal carcinoma | KG + DL |
| 44 | mycobacterium tuberculosis, susceptibility to | KG + DL |
| 45 | childhood malignant kidney neoplasm | KG + DL |
| 46 | combined immunodeficiency due to DOCK8 deficiency | KG + DL |
| 47 | cryptogenic organizing pneumonia | KG + DL |
| 48 | renal cell adenocarcinoma | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.